Lung Cancer Metastatic

Oncology·MeSH: Carcinoma, Non-Small-Cell Lung

10 drugs in development·5 companies·4 clinical trials

Drug Pipeline by Phase

Phase 3(3)

Drug	Company
acasunlimab	Genmab A/S (GMAB)
Pemetrexed	ENANTA PHARMACEUTICALS INC (ENTA)
Vinorelbine Tartrate	ENANTA PHARMACEUTICALS INC (ENTA)

Phase 2(4)

Drug	Company
etrumadenant	Arcus Biosciences, Inc. (RCUS)
Etrumadenant	Arcus Biosciences, Inc. (RCUS)
Pemetrexed	Arcus Biosciences, Inc. (RCUS)
Vinorelbine	ENANTA PHARMACEUTICALS INC (ENTA)

Phase 1(1)

Drug	Company
sar408701	Sanofi (SNY)

Phase 1/Phase 2(2)

Drug	Company
MCLA-129	Merus N.V. (MRUS)
Osimertinib	Merus N.V. (MRUS)

BioSniper tracks 10 drugs in development for Lung Cancer Metastatic across 5 companies.

There are 4 clinical trials targeting Lung Cancer Metastatic tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.